CurveBeam AI 

A$0.018000
2
-A$0.00-10% Monday 01:53

Statistics

Day High
0.019
Day Low
0.018
52W High
0.135
52W Low
0.016
Volume
337,709
Avg. Volume
549,454
Mkt Cap
8.38M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

30AugExpected
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Next
-0.03
-0.03
-0.02
-0.02
Expected EPS
N/A
Actual EPS
N/A

Financials

-139.23%Profit Margin
Unprofitable
2021
2023
2024
12.1MRevenue
-16.84MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
GE Aerospace
GE
Mkt Cap349.78B
General Electric, through its healthcare division, provides advanced imaging technologies that compete in the same space as CurveBeam AI's specialized imaging solutions.
Siemens
SIEGY
Mkt Cap239.92B
Siemens Healthineers offers a broad range of medical imaging equipment, including devices that directly compete with CurveBeam AI's extremity imaging technology.
Koninklijke Philips N.V.
PHG
Mkt Cap25.31B
Philips produces medical imaging systems that overlap with the technology offered by CurveBeam AI, particularly in the radiology segment.
Thermo Fisher Scientific
TMO
Mkt Cap226.94B
Thermo Fisher Scientific, while primarily focused on scientific instrumentation, also provides imaging technologies that can be used in similar applications as CurveBeam AI's products.
Danaher
DHR
Mkt Cap145.98B
Danaher, through its subsidiaries, manufactures medical imaging systems that compete with CurveBeam AI in terms of technology and market share.
Intuitive Surgical
ISRG
Mkt Cap129.55B
Intuitive Surgical, known for its robotic surgical systems, also utilizes advanced imaging technologies that can be seen as competitive to CurveBeam AI's offerings.
Boston Scientific
BSX
Mkt Cap69.27B
Boston Scientific, known for its medical devices, includes imaging technologies that can be applied in similar contexts to those served by CurveBeam AI.
Medtronic
MDT
Mkt Cap120.46B
Medtronic offers imaging and navigation systems that are used in various surgical and diagnostic applications, competing with CurveBeam AI's imaging solutions.

About

CurveBeam AI Limited engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe, North America, and internationally. The company offers HiRise for bilateral weight bearing CT imaging; LineUP, a bilateral, weight bearing CT imaging of the knees and lower extremities for orthpedic practices; pedCAT Premium and pedCAT for imaging of the foot and ankle; InReach, a point-of-care extremity CT imaging which assess the distal extremities with 3D clarity at a fraction of the dose; and CubeVue Software visualization tools. It also provides software CurveBeam AI Autometrics for automatically segment foot and ankle datasets; Axiometrics, provides a semi-automatic measurement of the axes of rotation of the hip, femur, knee, and ankle; and TALAS, a measurement tool that semi-automatically calculate hindfoot alignment based on reproducible three-dimensional anatomical landmarks. In addition, the company offers custom web-based cloud platform; and OSSView. The company was incorporated in 2009 and is headquartered in Hatfield, Pennsylvania.
Show more...
CEO
Mr. Gregory Wayne Brown BSc, MBA
Country
Australia
ISIN
AU0000289761

Listings

0 Comments

Share your thoughts

FAQ

What is CurveBeam AI stock price today?
The current price of CVB.AU is A$0.02 AUD — it has decreased by -10% in the past 24 hours. Watch CurveBeam AI stock price performance more closely on the chart.
What is CurveBeam AI stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on Australia Exchange exchange CurveBeam AI stocks are traded under the ticker CVB.AU.
Is CurveBeam AI stock price growing?
CVB.AU stock has fallen by -10% compared to the previous week, the month change is a +0% rise, over the last year CurveBeam AI has showed a -84.35% decrease.
What is CurveBeam AI market cap?
Today CurveBeam AI has the market capitalization of 8.38M
When is the next CurveBeam AI earnings date?
CurveBeam AI is going to release the next earnings report on March 04, 2027.
What is CurveBeam AI revenue for the last year?
CurveBeam AI revenue for the last year amounts to 12.1M AUD.
What is CurveBeam AI net income for the last year?
CVB.AU net income for the last year is -16.84M AUD.
In which sector is CurveBeam AI located?
CurveBeam AI operates in the Health & Wellness sector.
When did CurveBeam AI complete a stock split?
CurveBeam AI has not had any recent stock splits.
Where is CurveBeam AI headquartered?
CurveBeam AI is headquartered in Hatfield, Australia.